{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:40:47Z","timestamp":1779183647783,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T00:00:00Z","timestamp":1614470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T00:00:00Z","timestamp":1614470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P50 NS108675"],"award-info":[{"award-number":["P50 NS108675"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS064934"],"award-info":[{"award-number":["R01 NS064934"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00401-021-02288-1","type":"journal-article","created":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T10:02:47Z","timestamp":1614506567000},"page":"547-564","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Heterogeneity in \u03b1-synuclein fibril activity correlates to disease phenotypes in Lewy body dementia"],"prefix":"10.1007","volume":"141","author":[{"given":"Arpine","family":"Sokratian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Ziaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaela","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enquan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua Y.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Hsiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Ervin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandip M.","family":"Swain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodger A.","family":"Liddle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3034-4061","authenticated-orcid":false,"given":"Andrew B.","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,28]]},"reference":[{"key":"2288_CR1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.nbd.2017.05.014","volume":"105","author":"H Abdelmotilib","year":"2017","unstructured":"Abdelmotilib H, Maltbie T, Delic V, Liu Z, Hu X, Fraser KB et al (2017) \u03b1-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic neurodegeneration. Neurobiol Dis 105:84\u201398. https:\/\/doi.org\/10.1016\/j.nbd.2017.05.014","journal-title":"Neurobiol Dis"},{"key":"2288_CR2","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1038\/ncomms3575","volume":"4","author":"L Bousset","year":"2013","unstructured":"Bousset L, Pieri L, Ruiz-Arlandis G, Gath J, Jensen PH, Habenstein B et al (2013) Structural and functional characterization of two alpha-synuclein strains. Nat Commun 4:2575. https:\/\/doi.org\/10.1038\/ncomms3575","journal-title":"Nat Commun"},{"key":"2288_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/jnc.14965","volume":"153","author":"IC Br\u00e1s","year":"2020","unstructured":"Br\u00e1s IC, Dominguez-Meijide A, Gerhardt E, Koss D, L\u00e1zaro DF, Santos PI et al (2020) Synucleinopathies: where we are and where we need to go. J Neurochem 153:433\u2013454. https:\/\/doi.org\/10.1111\/jnc.14965","journal-title":"J Neurochem"},{"key":"2288_CR4","doi-asserted-by":"publisher","first-page":"12285","DOI":"10.1073\/pnas.0603216103","volume":"103","author":"MJ Buehler","year":"2006","unstructured":"Buehler MJ (2006) Nature designs tough collagen: explaining the nanostructure of collagen fibrils. Proc Natl Acad Sci USA 103:12285\u201312290. https:\/\/doi.org\/10.1073\/pnas.0603216103","journal-title":"Proc Natl Acad Sci USA"},{"key":"2288_CR5","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1042\/bcj20160868","volume":"476","author":"AK Buell","year":"2019","unstructured":"Buell AK (2019) The growth of amyloid fibrils: rates and mechanisms. Biochem J 476:2677\u20132703. https:\/\/doi.org\/10.1042\/bcj20160868","journal-title":"Biochem J"},{"key":"2288_CR6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/ana.25446","volume":"85","author":"N Candelise","year":"2019","unstructured":"Candelise N, Schmitz M, Llorens F, Villar-Piqu\u00e9 A, Cramm M, Thom T et al (2019) Seeding variability of different alpha synuclein strains in synucleinopathies. Ann Neurol 85:691\u2013703. https:\/\/doi.org\/10.1002\/ana.25446","journal-title":"Ann Neurol"},{"key":"2288_CR7","doi-asserted-by":"publisher","first-page":"11119","DOI":"10.1073\/pnas.0901422106","volume":"106","author":"E Chatani","year":"2009","unstructured":"Chatani E, Lee YH, Yagi H, Yoshimura Y, Naiki H, Goto Y (2009) Ultrasonication-dependent production and breakdown lead to minimum-sized amyloid fibrils. Proc Natl Acad Sci USA 106:11119\u201311124. https:\/\/doi.org\/10.1073\/pnas.0901422106","journal-title":"Proc Natl Acad Sci USA"},{"key":"2288_CR8","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","volume":"38","author":"GF Chen","year":"2017","unstructured":"Chen GF, Xu TH, Yan Y, Zhou YR, Jiang Y, Melcher K et al (2017) Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin 38:1205\u20131235. https:\/\/doi.org\/10.1038\/aps.2017.28","journal-title":"Acta Pharmacol Sin"},{"key":"2288_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","volume":"75","author":"F Chiti","year":"2006","unstructured":"Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75:333\u2013366. https:\/\/doi.org\/10.1146\/annurev.biochem.75.101304.123901","journal-title":"Annu Rev Biochem"},{"key":"2288_CR10","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1073\/pnas.97.2.571","volume":"97","author":"KA Conway","year":"2000","unstructured":"Conway KA, Lee SJ, Rochet JC, Ding TT, Williamson RE, Lansbury PT Jr (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson\u2019s disease: implications for pathogenesis and therapy. Proc Natl Acad Sci USA 97:571\u2013576. https:\/\/doi.org\/10.1073\/pnas.97.2.571","journal-title":"Proc Natl Acad Sci USA"},{"key":"2288_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/mds.27867","volume":"35","author":"DG Coughlin","year":"2020","unstructured":"Coughlin DG, Hurtig HI, Irwin DJ (2020) Pathological influences on clinical heterogeneity in Lewy body diseases. Mov Disord 35:5\u201319. https:\/\/doi.org\/10.1002\/mds.27867","journal-title":"Mov Disord"},{"key":"2288_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40035-019-0164-x","volume":"8","author":"CMG De Luca","year":"2019","unstructured":"De Luca CMG, Elia AE, Portaleone SM, Cazzaniga FA, Rossi M, Bistaffa E et al (2019) Efficient RT-QuIC seeding activity for \u03b1-synuclein in olfactory mucosa samples of patients with Parkinson\u2019s disease and multiple system atrophy. Transl Neurodegener 8:24. https:\/\/doi.org\/10.1186\/s40035-019-0164-x","journal-title":"Transl Neurodegener"},{"key":"2288_CR13","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1002\/cne.24468","volume":"526","author":"V Delic","year":"2018","unstructured":"Delic V, Chandra S, Abdelmotilib H, Maltbie T, Wang S, Kem D et al (2018) Sensitivity and specificity of phospho-Ser129 \u03b1-synuclein monoclonal antibodies. J Comp Neurol 526:1978\u20131990. https:\/\/doi.org\/10.1002\/cne.24468","journal-title":"J Comp Neurol"},{"key":"2288_CR14","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/acn3.338","volume":"3","author":"G Fairfoul","year":"2016","unstructured":"Fairfoul G, McGuire LI, Pal S, Ironside JW, Neumann J, Christie S et al (2016) Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. Ann Clin Transl Neurol 3:812\u2013818. https:\/\/doi.org\/10.1002\/acn3.338","journal-title":"Ann Clin Transl Neurol"},{"key":"2288_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ana.10846","volume":"55","author":"M Farrer","year":"2004","unstructured":"Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, Hulihan M et al (2004) Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 55:174\u2013179. https:\/\/doi.org\/10.1002\/ana.10846","journal-title":"Ann Neurol"},{"key":"2288_CR16","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/s1044-7431(03)00198-2","volume":"24","author":"S Gispert","year":"2003","unstructured":"Gispert S, Del Turco D, Garrett L, Chen A, Bernard DJ, Hamm-Clement J et al (2003) Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation. Mol Cell Neurosci 24:419\u2013429. https:\/\/doi.org\/10.1016\/s1044-7431(03)00198-2","journal-title":"Mol Cell Neurosci"},{"key":"2288_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","volume":"9","author":"M Goedert","year":"2013","unstructured":"Goedert M, Spillantini MG, Del Tredici K, Braak H (2013) 100 years of Lewy pathology. Nat Rev Neurol 9:13\u201324. https:\/\/doi.org\/10.1038\/nrneurol.2012.242","journal-title":"Nat Rev Neurol"},{"key":"2288_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40478-018-0508-2","volume":"6","author":"BR Groveman","year":"2018","unstructured":"Groveman BR, Orr\u00f9 CD, Hughson AG, Raymond LD, Zanusso G, Ghetti B et al (2018) Rapid and ultra-sensitive quantitation of disease-associated \u03b1-synuclein seeds in brain and cerebrospinal fluid by \u03b1Syn RT-QuIC. Acta Neuropathol Commun 6:7. https:\/\/doi.org\/10.1186\/s40478-018-0508-2","journal-title":"Acta Neuropathol Commun"},{"key":"2288_CR19","doi-asserted-by":"publisher","first-page":"14763","DOI":"10.1021\/ja805262v","volume":"130","author":"G Gu\u00e9rin","year":"2008","unstructured":"Gu\u00e9rin G, Wang H, Manners I, Winnik MA (2008) Fragmentation of fiberlike structures: sonication studies of cylindrical block copolymer micelles and behavioral comparisons to biological fibrils. J Am Chem Soc 130:14763\u201314771. https:\/\/doi.org\/10.1021\/ja805262v","journal-title":"J Am Chem Soc"},{"key":"2288_CR20","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.36402","author":"R Guerrero-Ferreira","year":"2018","unstructured":"Guerrero-Ferreira R, Taylor NM, Mona D, Ringler P, Lauer ME, Riek R et al (2018) Cryo-EM structure of alpha-synuclein fibrils. Elife. https:\/\/doi.org\/10.7554\/eLife.36402","journal-title":"Elife"},{"key":"2288_CR21","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1097\/00001756-199804200-00051","volume":"9","author":"L Hong","year":"1998","unstructured":"Hong L, Ko HW, Gwag BJ, Joe E, Lee S, Kim YT et al (1998) The cDNA cloning and ontogeny of mouse alpha-synuclein. NeuroReport 9:1239\u20131243. https:\/\/doi.org\/10.1097\/00001756-199804200-00051","journal-title":"NeuroReport"},{"key":"2288_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC et al (2012) National institute on aging-Alzheimer\u2019s association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement 8:1\u201313. https:\/\/doi.org\/10.1016\/j.jalz.2011.10.007","journal-title":"Alzheimers Dement"},{"key":"2288_CR23","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/mds.27646","volume":"34","author":"UJ Kang","year":"2019","unstructured":"Kang UJ, Boehme AK, Fairfoul G, Shahnawaz M, Ma TC, Hutten SJ et al (2019) Comparative study of cerebrospinal fluid \u03b1-synuclein seeding aggregation assays for diagnosis of Parkinson\u2019s disease. Mov Disord 34:536\u2013544. https:\/\/doi.org\/10.1002\/mds.27646","journal-title":"Mov Disord"},{"key":"2288_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13195-014-0073-2","volume":"6","author":"WS Kim","year":"2014","unstructured":"Kim WS, K\u00e5gedal K, Halliday GM (2014) Alpha-synuclein biology in Lewy body diseases. Alzheimers Res Ther 6:73. https:\/\/doi.org\/10.1186\/s13195-014-0073-2","journal-title":"Alzheimers Res Ther"},{"key":"2288_CR25","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1126\/science.1178250","volume":"326","author":"TP Knowles","year":"2009","unstructured":"Knowles TP, Waudby CA, Devlin GL, Cohen SI, Aguzzi A, Vendruscolo M et al (2009) An analytical solution to the kinetics of breakable filament assembly. Science 326:1533\u20131537. https:\/\/doi.org\/10.1126\/science.1178250","journal-title":"Science"},{"issue":"Suppl 1","key":"2288_CR26","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.parkreldis.2015.09.007","volume":"22","author":"T Konno","year":"2016","unstructured":"Konno T, Ross OA, Puschmann A, Dickson DW, Wszolek ZK (2016) Autosomal dominant Parkinson\u2019s disease caused by SNCA duplications. Parkinsonism Relat Disord 22(Suppl 1):S1-6. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.09.007","journal-title":"Parkinsonism Relat Disord"},{"key":"2288_CR27","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/hmg\/ddq038","volume":"19","author":"YM Kuo","year":"2010","unstructured":"Kuo YM, Li Z, Jiao Y, Gaborit N, Pani AK, Orrison BM et al (2010) Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. Hum Mol Genet 19:1633\u20131650. https:\/\/doi.org\/10.1093\/hmg\/ddq038","journal-title":"Hum Mol Genet"},{"key":"2288_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41593-019-0541-x","volume":"23","author":"A Lau","year":"2020","unstructured":"Lau A, So RWL, Lau HHC, Sang JC, Ruiz-Riquelme A, Fleck SC et al (2020) \u03b1-Synuclein strains target distinct brain regions and cell types. Nat Neurosci 23:21\u201331. https:\/\/doi.org\/10.1038\/s41593-019-0541-x","journal-title":"Nat Neurosci"},{"key":"2288_CR29","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s40478-019-0804-5","volume":"7","author":"I Lavenir","year":"2019","unstructured":"Lavenir I, Passarella D, Masuda-Suzukake M, Curry A, Holton JL, Ghetti B et al (2019) Silver staining (Campbell-Switzer) of neuronal \u03b1-synuclein assemblies induced by multiple system atrophy and Parkinson\u2019s disease brain extracts in transgenic mice. Acta Neuropathol Commun 7:148. https:\/\/doi.org\/10.1186\/s40478-019-0804-5","journal-title":"Acta Neuropathol Commun"},{"key":"2288_CR30","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1038\/s41467-018-05971-2","volume":"9","author":"B Li","year":"2018","unstructured":"Li B, Ge P, Murray KA, Sheth P, Zhang M, Nair G et al (2018) Cryo-EM of full-length \u03b1-synuclein reveals fibril polymorphs with a common structural kernel. Nat Commun 9:3609. https:\/\/doi.org\/10.1038\/s41467-018-05971-2","journal-title":"Nat Commun"},{"key":"2288_CR31","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm V, Carroll J, Zhang B, O\u2019Brien P, Trojanowski JQ et al (2012) Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338:949\u2013953. https:\/\/doi.org\/10.1126\/science.1227157","journal-title":"Science"},{"key":"2288_CR32","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/wnl.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium. Neurology 89:88\u2013100. https:\/\/doi.org\/10.1212\/wnl.0000000000004058","journal-title":"Neurology"},{"key":"2288_CR33","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 65:1863\u20131872. https:\/\/doi.org\/10.1212\/01.wnl.0000187889.17253.b1","journal-title":"Neurology"},{"key":"2288_CR34","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m","volume":"46","author":"CA McLean","year":"1999","unstructured":"McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K et al (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease. Ann Neurol 46:860\u2013866. https:\/\/doi.org\/10.1002\/1531-8249(199912)46:6%3c860::aid-ana8%3e3.0.co;2-m","journal-title":"Ann Neurol"},{"key":"2288_CR35","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00415-009-5324-y","volume":"257","author":"PT Nelson","year":"2010","unstructured":"Nelson PT, Jicha GA, Kryscio RJ, Abner EL, Schmitt FA, Cooper G et al (2010) Low sensitivity in clinical diagnoses of dementia with Lewy bodies. J Neurol 257:359\u2013366. https:\/\/doi.org\/10.1007\/s00415-009-5324-y","journal-title":"J Neurol"},{"key":"2288_CR36","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1002\/pro.3275","volume":"26","author":"B Nizynski","year":"2017","unstructured":"Nizynski B, Dzwolak W, Nieznanski K (2017) Amyloidogenesis of Tau protein. Protein Sci 26:2126\u20132150. https:\/\/doi.org\/10.1002\/pro.3275","journal-title":"Protein Sci"},{"key":"2288_CR37","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","volume":"557","author":"C Peng","year":"2018","unstructured":"Peng C, Gathagan RJ, Covell DJ, Medellin C, Stieber A, Robinson JL et al (2018) Cellular milieu imparts distinct pathological \u03b1-synuclein strains in \u03b1-synucleinopathies. Nature 557:558\u2013563. https:\/\/doi.org\/10.1038\/s41586-018-0104-4","journal-title":"Nature"},{"key":"2288_CR38","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.bpj.2017.09.003","volume":"113","author":"Z Peng","year":"2017","unstructured":"Peng Z, Parker AS, Peralta MDR, Ravikumar KM, Cox DL, Toney MD (2017) High tensile strength of engineered \u03b2-solenoid fibrils via sonication and pulling. Biophys J 113:1945\u20131955. https:\/\/doi.org\/10.1016\/j.bpj.2017.09.003","journal-title":"Biophys J"},{"key":"2288_CR39","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/jpd-171248","volume":"8","author":"NK Polinski","year":"2018","unstructured":"Polinski NK, Volpicelli-Daley LA, Sortwell CE, Luk KC, Cremades N, Gottler LM et al (2018) Best practices for generating and using alpha-synuclein pre-formed fibrils to model Parkinson\u2019s disease in rodents. J Parkinsons Dis 8:303\u2013322. https:\/\/doi.org\/10.3233\/jpd-171248","journal-title":"J Parkinsons Dis"},{"key":"2288_CR40","doi-asserted-by":"publisher","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","volume":"112","author":"SB Prusiner","year":"2015","unstructured":"Prusiner SB, Woerman AL, Mordes DA, Watts JC, Rampersaud R, Berry DB et al (2015) Evidence for \u03b1-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci USA 112:E5308-5317. https:\/\/doi.org\/10.1073\/pnas.1514475112","journal-title":"Proc Natl Acad Sci USA"},{"key":"2288_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","volume":"140","author":"M Rossi","year":"2020","unstructured":"Rossi M, Candelise N, Baiardi S, Capellari S, Giannini G, Orr\u00f9 CD et al (2020) Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol 140:49\u201362. https:\/\/doi.org\/10.1007\/s00401-020-02160-8","journal-title":"Acta Neuropathol"},{"key":"2288_CR42","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/2211-5463.12844","volume":"10","author":"VC Ruf","year":"2020","unstructured":"Ruf VC, Shi S, Schmidt F, Weckbecker D, N\u00fcbling GS, K\u00f6del U et al (2020) Potential sources of interference with the highly sensitive detection and quantification of alpha-synuclein seeds by qRT-QuIC. FEBS Open Bio 10:883\u2013893. https:\/\/doi.org\/10.1002\/2211-5463.12844","journal-title":"FEBS Open Bio"},{"key":"2288_CR43","doi-asserted-by":"publisher","first-page":"fcaa010","DOI":"10.1093\/braincomms\/fcaa010","volume":"2","author":"JB Sanderson","year":"2020","unstructured":"Sanderson JB, De S, Jiang H, Rovere M, Jin M, Zaccagnini L et al (2020) Analysis of \u03b1-synuclein species enriched from cerebral cortex of humans with sporadic dementia with Lewy bodies. Brain Commun 2:fcaa010. https:\/\/doi.org\/10.1093\/braincomms\/fcaa010","journal-title":"Brain Commun"},{"key":"2288_CR44","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","volume":"585","author":"M Schweighauser","year":"2020","unstructured":"Schweighauser M, Shi Y, Tarutani A, Kametani F, Murzin AG, Ghetti B et al (2020) Structures of \u03b1-synuclein filaments from multiple system atrophy. Nature 585:464\u2013469. https:\/\/doi.org\/10.1038\/s41586-020-2317-6","journal-title":"Nature"},{"key":"2288_CR45","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","volume":"578","author":"M Shahnawaz","year":"2020","unstructured":"Shahnawaz M, Mukherjee A, Pritzkow S, Mendez N, Rabadia P, Liu X et al (2020) Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy. Nature 578:273\u2013277. https:\/\/doi.org\/10.1038\/s41586-020-1984-7","journal-title":"Nature"},{"key":"2288_CR46","doi-asserted-by":"publisher","first-page":"15806","DOI":"10.1073\/pnas.0604035103","volume":"103","author":"JF Smith","year":"2006","unstructured":"Smith JF, Knowles TP, Dobson CM, Macphee CE, Welland ME (2006) Characterization of the nanoscale properties of individual amyloid fibrils. Proc Natl Acad Sci USA 103:15806\u201315811. https:\/\/doi.org\/10.1073\/pnas.0604035103","journal-title":"Proc Natl Acad Sci USA"},{"key":"2288_CR47","doi-asserted-by":"publisher","first-page":"5535","DOI":"10.1038\/s41467-019-13564-w","volume":"10","author":"T Stroh\u00e4ker","year":"2019","unstructured":"Stroh\u00e4ker T, Jung BC, Liou SH, Fernandez CO, Riedel D, Becker S et al (2019) Structural heterogeneity of \u03b1-synuclein fibrils amplified from patient brain extracts. Nat Commun 10:5535. https:\/\/doi.org\/10.1038\/s41467-019-13564-w","journal-title":"Nat Commun"},{"key":"2288_CR48","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40478-018-0532-2","volume":"6","author":"A Tarutani","year":"2018","unstructured":"Tarutani A, Arai T, Murayama S, Hisanaga SI, Hasegawa M (2018) Potent prion-like behaviors of pathogenic \u03b1-synuclein and evaluation of inactivation methods. Acta Neuropathol Commun 6:29. https:\/\/doi.org\/10.1186\/s40478-018-0532-2","journal-title":"Acta Neuropathol Commun"},{"key":"2288_CR49","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00401-020-02157-3","volume":"139","author":"A Van der Perren","year":"2020","unstructured":"Van der Perren A, Gelders G, Fenyi A, Bousset L, Brito F, Peelaerts W et al (2020) The structural differences between patient-derived \u03b1-synuclein strains dictate characteristics of Parkinson\u2019s disease, multiple system atrophy and dementia with Lewy bodies. Acta Neuropathol 139:977\u20131000. https:\/\/doi.org\/10.1007\/s00401-020-02157-3","journal-title":"Acta Neuropathol"},{"key":"2288_CR50","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1002\/mds.111","volume":"33","author":"I van Steenoven","year":"2018","unstructured":"van Steenoven I, Majbour NK, Vaikath NN, Berendse HW, van der Flier WM, van de Berg WDJ et al (2018) \u03b1-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies. Mov Disord 33:1724\u20131733. https:\/\/doi.org\/10.1002\/mds.111","journal-title":"Mov Disord"},{"key":"2288_CR51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ana.410350110","volume":"35","author":"CH Waters","year":"1994","unstructured":"Waters CH, Miller CA (1994) Autosomal dominant Lewy body parkinsonism in a four-generation family. Ann Neurol 35:59\u201364. https:\/\/doi.org\/10.1002\/ana.410350110","journal-title":"Ann Neurol"},{"key":"2288_CR52","doi-asserted-by":"publisher","first-page":"34272","DOI":"10.1074\/jbc.M109.049809","volume":"284","author":"WF Xue","year":"2009","unstructured":"Xue WF, Hellewell AL, Gosal WS, Homans SW, Hewitt EW, Radford SE (2009) Fibril fragmentation enhances amyloid cytotoxicity. J Biol Chem 284:34272\u201334282. https:\/\/doi.org\/10.1074\/jbc.M109.049809","journal-title":"J Biol Chem"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-021-02288-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-021-02288-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-021-02288-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T16:39:09Z","timestamp":1615480749000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-021-02288-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,28]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["2288"],"URL":"https:\/\/doi.org\/10.1007\/s00401-021-02288-1","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,28]]},"assertion":[{"value":"22 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}